Order Article Reprints

Burgaz S, García C, Gonzalo-Consuegra C, Gómez-Almería M, Ruiz-Pino F, Unciti JD, Gómez-Cañas M, Alcalde J, Morales P, Jagerovic N, et al. Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis. Molecules. 2021; 26(24):7643. https://doi.org/10.3390/molecules26247643

Burgaz, Sonia, Concepción García, Claudia Gonzalo-Consuegra, Marta Gómez-Almería, Francisco Ruiz-Pino, Juan Diego Unciti, María Gómez-Cañas, Juan Alcalde, Paula Morales, Nadine Jagerovic, and et al. 2021. "Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis" Molecules 26, no. 24: 7643. https://doi.org/10.3390/molecules26247643

Burgaz, S., García, C., Gonzalo-Consuegra, C., Gómez-Almería, M., Ruiz-Pino, F., Unciti, J. D., Gómez-Cañas, M., Alcalde, J., Morales, P., Jagerovic, N., Rodríguez-Cueto, C., de Lago, E., Muñoz, E., & Fernández-Ruiz, J. (2021). Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis. Molecules, 26(24), 7643. https://doi.org/10.3390/molecules26247643